Results 61 to 70 of about 12,068 (157)

COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION

Рациональная фармакотерапия в кардиологии, 2016
Aim. To compare efficacy of carvedilol and bisoprolol in patients with chronic heart failure (CHF) and diabetes mellitus (DM) type 2 after myocardial infarction (MI).Material and methods.
M. E. Statsenko, S. V. Belenkova, O. E. Sporova, D. A. Ivanova, E. D. Evtereva   +4 more
doaj   +1 more source

Clinicohemodynamic efficacy of a selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease

Терапевтический архив, 2004
Aim. To assess the effect of a long-term (6 months) treatment with selective beta-blocker bisoprolol, cytoprotector trimetazidine and their combination on the clinical course, left ventricular morphofunctional parameters and quality of life of patients ...
Т A Fedorova, Yu V Ilyina, Т I Sotnikova, M К Rybakova, N V Loschits   +4 more
doaj  

Effects of β1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease

Терапевтический архив, 2009
Aim. To study effects of a cardioselective beta-adrenoblocker bisoprolol on vascular wall endothelium and external respiration function in stable angina of effort combined with chronic obstructive pulmonary disease (COPD).
N Yu Grigor'eva, E G Sharabrin, A N Kuznetsov, K V Mazalov, K N Kontorshchikova, E F Koroleva, N Yu Grigorieva, E G Sharabrin, A N Kuznetsov, K V Mazalov, K N Kontorschikova, E F Koroleva   +11 more
doaj  

NT-proBNP LEVEL CHANGES AFTER COMBINATION THERAPY WITH BISOPROLOL AND ACE-INHIBITOR IN PATIENT WITH HEART FAILURE

Folia Medica Indonesiana, 2017
Heart failure (HF) is the final common stage of many diseases of the heart. NT-proBNP levels are increased in HF and correlate well with ventricular wall stress and severity of HF. Combination therapy with Bisoprolol and ACE-inhibitor decreases NT-proBNP
Reine Risa Risthanti, Muhammad Aminuddin, Suharjono Suharjono   +2 more
doaj   +1 more source

Bisoprolol transdermal patch for perioperative care of non-cardiac surgery in patients with hypertrophic obstructive cardiomyopathy

BMC Cardiovascular Disorders, 2019
Background Non-cardiac surgery for hypertrophic obstructive cardiomyopathy (HOCM) is considered to require meticulous perioperative care. β-blockers are considered the first-line drugs for patients with HOCM, and they play a key role in preventing ...
Yoichi Imori, Hitoshi Takano, Hiroshi Mase, Junya Matsuda, Hideto Sangen, Yuki Izumi, Yukichi Tokita, Takeshi Yamamoto, Wataru Shimizu   +8 more
doaj   +1 more source

COMPARISON OF CLINICAL EFFICACY OF ORIGINAL BISOPROLOL AND ITS GENERIC DRUG IN PATIENTS WITH STABLE ANGINA AND CONCOMITANT CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Рациональная фармакотерапия в кардиологии, 2016
Aim. To compare clinical efficacy and effect on endothelium function of original bisoprolol and its generic in patients with stable angina and concomitant chronic obstructive pulmonary disease (COPD).Material and methods.
N. Yu. Grigorieva, E. G. Sharabrin, A. N. Kuznetsov   +2 more
doaj   +1 more source

Autonomic Modulation in Patients with Heart Failure Increases Beat-to-Beat Variability of Ventricular Action Potential Duration

Frontiers in Physiology, 2017
Background: Exaggerated beat-to-beat variability of ventricular action potential duration (APD) is linked to arrhythmogenesis. Sympathetic stimulation has been shown to increase QT interval variability, but its effect on ventricular APD in humans has not
Bradley Porter, Martin J. Bishop, Simon Claridge, Jonathan Behar, Benjamin J. Sieniewicz, Jessica Webb, Justin Gould, Mark O'Neill, Christopher A. Rinaldi, Reza Razavi, Jaswinder S. Gill, Peter Taggart   +11 more
doaj   +1 more source

Bisoprolol medications in a comparative study on effectiveness and tolerability of original agent and its generic in patients with mild to moderate arterial hypertension

Кардиоваскулярная терапия и профилактика, 2007
Aim. To study clinical equivalence of two bisoprolol medications (Concor ® and Bisogamma®) in patients with mild to moderate arterial hypertension (AH). Material and methods. The study included 32 AH patients (15 men, 17 women): 66 % with Stage I, and 34
S. Yu. Martsevich, S. N. Tolpygina, E. V. Shilova, N. P. Kutishenko, O. V. Lerman, N. A. Dmitrieva, Yu. V. Lukina, V. P. Voronina, A. A. Serazhim   +8 more
doaj  

Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT

Health Technology Assessment
Background Observational studies of people with chronic obstructive pulmonary disease using beta-blockers for cardiovascular disease indicate that beta-blocker use is associated with reduced risk of chronic obstructive pulmonary disease exacerbation ...
Graham Devereux, Seonaidh Cotton, Mintu Nath, Nicola McMeekin, Karen Campbell, Rekha Chaudhuri, Gourab Choudhury, Anthony De Soyza, Shona Fielding, Simon Gompertz, John Haughney, Amanda Lee, Graeme MacLennan, Alyn Morice, John Norrie, David Price, Philip Short, Jorgen Vestbo, Paul Walker, Jadwiga Wedzicha, Andrew Wilson, Olivia Wu, Brian Lipworth   +22 more
doaj   +1 more source

Bisoprolol in cardiovascular disease treatment

Кардиоваскулярная терапия и профилактика, 2008
Literature data are presented on the role of beta-adrenoblockers (BAB) and bisoprolol, in particular, in the treatment of cardiovascular disease (CVD), including coronary heart disease (CHD), chronic heart failure, arterial hypertension (AH) and cardiac ...
S. N. Tolpygina, S. Yu. Martsevich
doaj